CME on "Technological Advancements in Nephrology, Urology & Renal Transplantation"

CME on
Ludhiana, March 10, 2019: Aykai Hospital in collaboration with Fresenius Medical Care and Punjab Nephrology Society organised a CME Nephrology Update 2019 on "Technological Advancements in Nephrology, Urology & Renal Transplantation" at Hotel Park Plaza Ludhiana on 9th March to discuss latest advancement in the field of kidney diseases and transplantation. This CME was inaugurated by Professor Vivekanand Jha, the President of International Society of Nephrology. Professor V Jha is the first Indian to rise to this prestigious post after a long distinguished period at PGI. Eminent senior nephrology experts delievered the lectures on the new developments in various fields of nephrology and renal transplantation. The faculty included : Prof. Vivekanand Jha- the president of International Society of Nephrology, Prof. O P Kalra, Vice Chancellor of Pt. Bhagwant Dayal Sharma University of Health Sciences, Rohtak, Prof. Ashwani Gupta from Sir Ganga Ram Hospital, New Delhi, Prof. (General) AS Narula and (General) PP Varma, formerly HODs at Military Hospital (R&R) New Delhi and Dr Raja Ramachandran from PGI Chandigarh. More than 100 nephrologists, physicians and urologists from the state of Punjab, Chandigarh and J&K attended the CME. Dr V Jha discussed on Kidney Regeneration. He said that that stem cell treatment is an advance technique for kidney regeneration. Several types of stem cells, such as bone marrow-derived cells, adipocyte-derived mesenchymal stem cells, embryonic stem cells, and induced pluripotent stem cells are also applied for renal regeneration. Endogenous or lineage reprogrammed renal progenitor cells represent an attractive possibility for differentiation into multiple renal cell types. However there are various factors like cost and duration of treatment, the same is not much practiced in India. Dr Raja Ramachandran , a specialist in Renal Medicine and presently in Post Graduate Institute of Medical Education and Research, Chandigarh, India and did fellowship from the same Institute updated on Pathogenesis/treatment of Membranous Nephropathy. Dr Ajit Singh Narula from fortis having over 30 years of teaching experience in various tertiary care hospitals of Armed Forces, including Armed Forces Medical College Pune and Army Hospital (Research & Referral), New Delhi discussed on Cardiac Therapeutics in chronic kidney diseases. Dr Ashwani Gupta, Sir Ganga Ram Hospital, Delhi updated on the ABO incompatible transplantation: challenges & outcome. He said rising demand of kidney transplant and limited availability of ABO-compatible kidney donors, ABO incompatible (ABOi) kidney transplant is a viable option. Prof. O P Kalra, Vice Chancellor of Pt. Bhagwant Dayal Sharma University of Health Sciences, Rohtak updated on Chronic kidney disease - Unknown (CKDu). While discussing on ADPKD- Whats New, Dr. PP varma said that Autosomal dominant polycystic kidney disease (ADPKD) is a multisystemic and progressive disorder characterized by cyst formation and enlargement in the kidney and other organs (eg, liver, pancreas, spleen). Up to 50% of patients with ADPKD require renal replacement therapy by 60 years of age. Dr. Baldev Singh Aulakh Director, Aykai Hospital & Urologist and Transplant Surgeon said that the update was a a great learning experience for the new things for the nephrologists, clinicians and provide specially for the young doctors. He said that at Aykai we are committed to provide the best support and care to our patients and we will continue to organize such programs with an approach to introduce best advanced knowledge and technique in this field. At the end of the program , Dr JS Sandhu- Director Nephrology, Aykai Hospital gave a vote of thanks to all the eminent speakers and those who attended the program. He said that within a short span of time Aykai has been able to provide best medical care to patients suffering from CKD. Dr. Manoj Sobti, Member Punjab Medical Council attended the CME on behalf of PMC and PMC has given two credit hours to the all the delegate doctors who have attended the CME.